CA1241641A - Osteogenic factors - Google Patents

Osteogenic factors

Info

Publication number
CA1241641A
CA1241641A CA000471370A CA471370A CA1241641A CA 1241641 A CA1241641 A CA 1241641A CA 000471370 A CA000471370 A CA 000471370A CA 471370 A CA471370 A CA 471370A CA 1241641 A CA1241641 A CA 1241641A
Authority
CA
Canada
Prior art keywords
protein
bone
proteins
osteogenic
calf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000471370A
Other languages
English (en)
French (fr)
Inventor
Arup Sen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Genetic Engineering Inc
Original Assignee
International Genetic Engineering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Genetic Engineering Inc filed Critical International Genetic Engineering Inc
Application granted granted Critical
Publication of CA1241641A publication Critical patent/CA1241641A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Magnetic Heads (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000471370A 1984-01-04 1985-01-03 Osteogenic factors Expired CA1241641A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56816784A 1984-01-04 1984-01-04
US568,167 1984-01-04

Publications (1)

Publication Number Publication Date
CA1241641A true CA1241641A (en) 1988-09-06

Family

ID=24270176

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000471370A Expired CA1241641A (en) 1984-01-04 1985-01-03 Osteogenic factors

Country Status (11)

Country Link
EP (1) EP0148155B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60226814A (cg-RX-API-DMAC7.html)
AT (1) ATE42309T1 (cg-RX-API-DMAC7.html)
AU (1) AU580975B2 (cg-RX-API-DMAC7.html)
CA (1) CA1241641A (cg-RX-API-DMAC7.html)
DE (1) DE3569542D1 (cg-RX-API-DMAC7.html)
DK (1) DK161524C (cg-RX-API-DMAC7.html)
GR (1) GR850006B (cg-RX-API-DMAC7.html)
IE (1) IE57966B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ210699A (cg-RX-API-DMAC7.html)
ZA (1) ZA8547B (cg-RX-API-DMAC7.html)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4627982A (en) * 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
JPH0723322B2 (ja) * 1985-12-07 1995-03-15 克之 藤井 液状骨形成剤からなる注射液
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US4877864A (en) * 1987-03-26 1989-10-31 Genetics Institute, Inc. Osteoinductive factors
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0271668B1 (de) * 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Wachstumstimulierendes Material, Herstellungsverfahren und therapeutische Zusammensetzung
AU3433989A (en) * 1988-04-06 1989-11-03 Celtrix Laboratories, Inc. Bone-inducing protein
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US5250302A (en) * 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
EP0362367B1 (en) * 1988-04-08 1996-02-28 Stryker Corporation Osteogenic devices
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US4968590A (en) * 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5670336A (en) * 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US4975526A (en) * 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
IL90683A0 (en) * 1988-06-27 1990-01-18 Yissum Res Dev Co Osteogenic growth factors derived from regenerating bone marrow
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
JPH03151877A (ja) * 1989-06-02 1991-06-28 Chiron Corp 骨カルシウム沈着因子
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
WO1991005802A1 (en) * 1989-10-17 1991-05-02 Creative Biomolecules, Inc. Osteogenic devices
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US6949505B1 (en) 1991-03-11 2005-09-27 Curis, Inc. Morphogen-induced dendritic growth
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US5656593A (en) * 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5972884A (en) * 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5739107A (en) 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
JP3504263B2 (ja) 1991-11-04 2004-03-08 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 組み換え型骨形態形成蛋白ヘテロダイマー、組成物および使用法
KR100227406B1 (ko) 1993-05-12 1999-12-01 브루스 엠. 에이센 Bmp-11 조성물
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
JP3717930B2 (ja) 1993-12-07 2005-11-16 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Ｂｍｐ−１２、ｂｍｐ−１３およびそれらの腱誘導組成物
US5928940A (en) * 1996-09-24 1999-07-27 Creative Biomolecules, Inc. Morphogen-responsive signal transducer and methods of use thereof
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
CA2386408A1 (en) 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
AU2003240196A1 (en) 2002-06-20 2004-01-23 Nicolaas Duneas Osteoinductive biomaterials
CN1878565B (zh) 2003-09-12 2011-01-12 惠氏公司 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂
CA2535169A1 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
AU2005266875B2 (en) 2004-07-23 2012-07-26 Acceleron Pharma Inc. ActRII receptor polypeptides, methods and compositions
EP1942960B1 (en) 2005-11-01 2012-08-29 Warsaw Orthopedic, Inc. Methods for producing bone matrix composition
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
WO2008157497A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Method of treating tissue
AU2008265850B2 (en) 2007-06-15 2014-06-26 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9358113B2 (en) 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
CA2702499A1 (en) 2007-10-19 2009-04-23 Osteotech, Inc. Demineralized bone matrix compositions and methods
WO2010093950A1 (en) 2009-02-12 2010-08-19 Osteotech, Inc. Delivery system cartridge
JP6267425B2 (ja) 2009-11-17 2018-01-24 アクセルロン ファーマ， インコーポレイテッド 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
CN110036025B (zh) 2016-10-05 2024-03-22 阿塞勒隆制药公司 变体ActRIIB蛋白及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4608199A (en) * 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process

Also Published As

Publication number Publication date
JPS60226814A (ja) 1985-11-12
EP0148155B1 (en) 1989-04-19
IE850010L (en) 1985-07-04
DK161524B (da) 1991-07-15
EP0148155A2 (en) 1985-07-10
IE57966B1 (en) 1993-06-02
AU580975B2 (en) 1989-02-09
GR850006B (cg-RX-API-DMAC7.html) 1985-05-03
AU3722184A (en) 1985-07-11
ATE42309T1 (de) 1989-05-15
DK161524C (da) 1991-12-23
DE3569542D1 (en) 1989-05-24
EP0148155A3 (en) 1986-08-13
DK2285D0 (da) 1985-01-02
NZ210699A (en) 1989-06-28
DK2285A (da) 1985-07-05
ZA8547B (en) 1986-09-24

Similar Documents

Publication Publication Date Title
CA1241641A (en) Osteogenic factors
US4804744A (en) Osteogenic factors
AU615810B2 (en) Osteogenic factors
US4795804A (en) Bone morphogenetic agents
Miller Isolation and characterization of the cyanogen bromide peptides from the. alpha. 1 (II) chain of chick cartilage collagen
Corder et al. Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue
EP0128849B1 (en) Purified transforming growth factor-beta derived from human platelets and placentas
EP0336760A2 (en) Bone-inducing protein
US4727137A (en) Purified protein having angiogenic activity and methods of preparation
US4746729A (en) Cartilage-derived leukocyte elastase-inhibitor
Rosenstreich et al. A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.
US4897464A (en) Purified protein having angiogenic activity and methods of preparation
EP0241136A2 (en) Human class 1 heparin-binding growth factor
Low et al. Thymosins: Isolation, structural studies, and biological activities
US5576301A (en) Low molecular growth potentiating peptides
EP0070569B1 (en) Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
Ogata Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1.
Block et al. A chemical relationship between the protein fractions obtained from fowl serum by cellulose ion-exchange chromatography. Evidence for an amino acid “anlage”
JP2000109500A (ja) ヒト尿由来細胞接着糖蛋白質、その製造方法およびそれを 含有する医薬品
WO1996011695A9 (en) Low molecular weight growth potentiating peptides
KR100371976B1 (ko) 혈장헤파린결합단백질-70
CA2191321A1 (en) Gene coding for modified bone morphogenic protein receptor
WO1991008749A1 (en) Novel procedure for obtaining proteins starting from an extract of non-collagenous proteins from bony material and its use for the preparation of a novel protein inhibiting the proliferation of osteoblasts
Landais et al. Localization of γ-Glutamyl-phosphate residues to the α2CB3–5 Peptide of type I Chicken bone collagen
WO1993016715A1 (en) Fsf-1 and the early detection of fibrosis

Legal Events

Date Code Title Description
MKEX Expiry